scholarly article | Q13442814 |
P50 | author | Vivian Iida Avelino-Silva | Q59258341 |
Alice Song | Q61946371 | ||
P2093 | author name string | Vincenzo Pugliese | |
Luiz Augusto Carneiro D'Albuquerque | |||
Edson Abdala | |||
Rafael Antonio Arruda Pecora | |||
P2860 | cites work | Piggy-back graft for liver transplantation | Q24235028 |
Primary living-donor liver transplantation at the University of Chicago: technical aspects of the first 104 recipients | Q24541621 | ||
HOMOTRANSPLANTATION OF THE LIVER IN HUMANS | Q24658552 | ||
Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients | Q27486519 | ||
Early indicators of prognosis in fulminant hepatic failure | Q28241473 | ||
Comparison of seven liver allocation models with respect to lives saved among patients on the liver transplant waiting list | Q28731277 | ||
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis | Q29619508 | ||
Right lobe living-donor liver transplantation with or without middle hepatic vein: a meta-analysis | Q34102248 | ||
Multivariate analysis of prognostic factors in fulminant hepatitis B. | Q34188794 | ||
Transection of the oesophagus for bleeding oesophageal varices | Q34211834 | ||
Operative morbidity of living liver donors in Japan | Q34228110 | ||
FK 506 for liver, kidney, and pancreas transplantation | Q34252199 | ||
Biliary complications in 96 consecutive right lobe living donor transplant recipients | Q34329858 | ||
Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. | Q34416701 | ||
Weaning of immunosuppression in liver transplant recipients | Q34421352 | ||
Model for end-stage liver disease-based allocation system for liver transplantation in Argentina: does it work outside the United States? | Q34538837 | ||
Surgical anatomy and anatomical surgery of the liver | Q70386490 | ||
Venous bypass in clinical liver transplantation | Q70386801 | ||
One surgeon's experience with the piggyback versus the standard technique in orthotopic liver transplantation: is one better than the other? | Q70964005 | ||
Successful living-related partial liver transplantation to an adult patient | Q72676755 | ||
Analysis of the complications of the piggy-back technique in 1112 liver transplants | Q73027583 | ||
Hepatic artery stenosis after liver transplantation--incidence, presentation, treatment, and long term outcome | Q73039504 | ||
Selective revascularization of hepatic artery thromboses after liver transplantation improves patient and graft survival | Q73884186 | ||
Biliary complications in adult living donor liver transplantation with duct-to-duct hepaticocholedochostomy or Roux-en-Y hepaticojejunostomy biliary reconstruction | Q74445233 | ||
Duct-to-duct biliary reconstruction in living donor liver transplantation utilizing right lobe graft | Q74593823 | ||
The immunoreactive propensity of autoimmune hepatitis: is It corticosteroid-dependent after liver transplantation? | Q78225745 | ||
Biliary reconstruction and complications of right lobe live donor liver transplantation | Q78455992 | ||
Experimental whole-organ transplantation of the liver and of the spleen | Q79076117 | ||
Toward current standards of donor right hepatectomy for adult-to-adult live donor liver transplantation through the experience of 200 cases | Q79467688 | ||
Safety of duct-to-duct biliary reconstruction in right-lobe live-donor liver transplantation without biliary drainage | Q79777393 | ||
MELD score, step forward to justice of liver graft allocation in Brazil | Q80148550 | ||
Duct-to-duct biliary reconstruction in adult living-donor liver transplantation | Q80783280 | ||
A common peripheral blood gene set for diagnosis of operational tolerance in pediatric and adult liver transplantation | Q83387375 | ||
Single artery reconstruction in left liver transplantation | Q83401474 | ||
Current status of liver transplantation | Q85580824 | ||
Outcome of routine use of microsurgical biliary reconstruction in pediatric living donor liver transplantation | Q86568534 | ||
Immunosuppression withdrawal following liver transplantation: the older, the wiser… but maybe too late | Q86965594 | ||
Reversibility of acquired amyloid polyneuropathy after liver retransplantation | Q87199171 | ||
Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation | Q34646976 | ||
Hepatic artery reconstruction in living donor liver transplantation: risk factor analysis of complication and a role of MDCT scan for detecting anastomotic stricture | Q34975316 | ||
Liver transplantation in patients with HIV infection. | Q35160315 | ||
Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation | Q35640630 | ||
Life expectancy of adult liver allograft recipients in the UK. | Q35761326 | ||
Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications | Q36280426 | ||
Indications of liver transplantation in patients with complications of cirrhosis | Q36708158 | ||
Current indications and contraindications for liver transplantation | Q36867887 | ||
Current concepts in transplant surgery: liver transplantation today | Q37097910 | ||
Portal vein grafts in hepatic transplantation. | Q37140923 | ||
Veno-venous bypass without systemic anticoagulation for transplantation of the human liver | Q37347248 | ||
Liver transplantation: the current situation | Q37398943 | ||
Immunologic Basis of Graft Rejection and Tolerance Following Transplantation of Liver or Other Solid Organs | Q37400370 | ||
Operational tolerance: past lessons and future prospects | Q37850763 | ||
Long-term results of liver transplantation | Q37863928 | ||
Evidence-based development of liver allocation: a review | Q37880205 | ||
Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system | Q37893109 | ||
Hepatic arterial stenosis assessed with doppler US after liver transplantation: frequent false-positive diagnoses with tardus parvus waveform and value of adding optimal peak systolic velocity cutoff | Q37898362 | ||
Liver transplantation in the 21st century: expanding the donor options | Q37926691 | ||
Outcomes with split liver transplantation in 106 recipients: the University of California, San Francisco, experience from 1993 to 2010. | Q37935447 | ||
A decade of model for end-stage liver disease: lessons learned and need for re-evaluation of allocation policies | Q38003833 | ||
Calcineurin inhibitors in liver transplantation - still champions or threatened by serious competitors? | Q38084753 | ||
Biomarkers of tolerance. | Q38120394 | ||
Liver function impairment in liver transplantation and after extended hepatectomy | Q38168828 | ||
Lessons learned from 1,000 living donor liver transplantations in a single center: how to make living donations safe | Q38510111 | ||
Seventeen adult-to-adult living donor liver transplantations using dual grafts | Q38523712 | ||
Orthotopic homotransplantation of the human liver | Q38540105 | ||
Prolonged survival of pig orthotopic heart grafts treated with cyclosporin A. | Q39492216 | ||
Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers | Q39574059 | ||
Transplantation of two patients with one liver. Analysis of a preliminary experience with 'split-liver' grafting | Q41939953 | ||
VENO-VENOUS BYPASS WITHOUT SYSTEMIC ANTICOAGULATION IN CANINE AND HUMAN LIVER TRANSPLANTATION. | Q42068677 | ||
Reconstructive problems in canine liver homotransplantation with special reference to the postoperative role of hepatic venous flow | Q42125990 | ||
Influence of antiviral therapy in the long-term outcome of recurrent hepatitis C virus infection following liver transplantation | Q42260788 | ||
Assessment of chronic rejection in liver graft recipients receiving immunosuppression with low-dose calcineurin inhibitors. | Q42277660 | ||
Trial of complete weaning from immunosuppression for liver transplant recipients: factors predictive of tolerance | Q42440224 | ||
A comparison of liver transplantation outcomes in the pre- vs. post-MELD eras | Q42646399 | ||
Multiparameter immune profiling of operational tolerance in liver transplantation | Q43035275 | ||
Randomized trial of choledochocholedochostomy with or without a T tube in orthotopic liver transplantation | Q43497220 | ||
Feasibility of split liver transplantation for 2 adults in the model of end-stage liver disease era. | Q43562799 | ||
Weaning of immunosuppression in living donor liver transplant recipients | Q43705848 | ||
Outcomes with split liver transplantation are equivalent to those with whole organ transplantation | Q43835446 | ||
Liver transplantation: past, present and future | Q44195675 | ||
Operational tolerance in liver transplantation: shall we predict or promote? | Q44369493 | ||
Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients | Q44498208 | ||
Postoperative liver regeneration and complication in live liver donor after partial hepatectomy for living donor liver transplantation | Q44711865 | ||
Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival | Q46743120 | ||
Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants | Q46811652 | ||
Extending the limit on the size of adult recipient in living donor liver transplantation using extended right lobe graft. | Q47308509 | ||
Cadaveric full-size liver transplantation and the graft alternatives in adults: a comparative study from a single centre | Q47365256 | ||
Late venous outflow obstruction after liver transplant: The 'piggy-back' syndrome | Q47638838 | ||
Biliary reconstructions and complications encountered in 50 consecutive right-lobe living donor liver transplantations. | Q47865177 | ||
Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma. | Q47982830 | ||
The long reach of liver transplantation | Q48288619 | ||
Liver transplantation--a vision realized. | Q48385516 | ||
The first report of orthotopic liver transplantation in the Western world | Q48461499 | ||
Estimates of early death, acute liver failure, and long-term mortality among live liver donors | Q48565211 | ||
Biliary reconstruction in right lobe living-donor liver transplantation: Comparison of different techniques in 321 recipients | Q50114384 | ||
Long-term follow-up after right hepatectomy for adult living donation and attitudes toward the procedure | Q50156345 | ||
Long-term outcomes of pediatric living donor liver transplantation in Japan: an analysis of more than 2200 cases listed in the registry of the Japanese Liver Transplantation Society. | Q51240343 | ||
A prospective policy development to increase split-liver transplantation for 2 adult recipients: results of a 12-year multicenter collaborative study. | Q51254681 | ||
Risk factors contributing to hepatic artery thrombosis following living-donor liver transplantation. | Q51814626 | ||
Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients. | Q51822089 | ||
Elective liver transplant list mortality: development of a United Kingdom end-stage liver disease score. | Q53149626 | ||
Hepatic artery reconstruction and successful management of its complications in living donor liver transplantation using a right lobe. | Q53404432 | ||
High hilar dissection: new technique to reduce biliary complication in living donor liver transplantation. | Q53635027 | ||
Liver Transplantation in Man--I, Observations on Technique and Organization in Five Cases | Q55185666 | ||
Defining the outcome of immunosuppression withdrawal after liver transplantation | Q58143634 | ||
Symptomatic and provende novoamyloid polyneuropathy in familial amyloid polyneuropathy domino liver recipients | Q58166021 | ||
Microvascular Reconstruction of the Hepatic Artery in Live Donor Liver Transplantation | Q59344171 | ||
Acute lobular hepatitis as the first manifestation of recurrent autoimmune hepatitis after orthotopic liver transplantation | Q62514023 | ||
OUTCOME OF AUTOIMMUNE HEPATITIS AFTER LIVER TRANSPLANTATION1 | Q62618608 | ||
Renal transplantation: a twenty-five year experience | Q67496103 | ||
[Transplantation of a donor liver to 2 recipients (splitting transplantation)--a new method in the further development of segmental liver transplantation] | Q68140836 | ||
Successful liver transplantation from a living donor to her son | Q68776762 | ||
Liver transplantation from live donors | Q69373252 | ||
Orthotopic liver transplantation with preservation of the inferior vena cava | Q69803089 | ||
National Institutes of Health Consensus Development Conference on Liver Transplantation. Sponsored by the National Institute of Arthritis, Diabetes, and Digestive and Kidney Diseases and the National Institutes of Health Office of Medical Applicatio | Q70314364 | ||
Reduced-sized orthotopic liver graft in hepatic transplantation in children | Q70328931 | ||
Landmark article Aug 5, 1968: A definition of irreversible coma. Report of the Ad Hoc Committee of the Harvard Medical School to examine the definition of brain death | Q70363644 | ||
P433 | issue | 18 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | liver transplantation | Q1368191 |
P304 | page(s) | 5363-5374 | |
P577 | publication date | 2014-05-01 | |
P1433 | published in | World Journal of Gastroenterology | Q15708885 |
P1476 | title | Liver transplantation: fifty years of experience | |
P478 | volume | 20 |
Q44338608 | Association between opioid use and readmission following liver transplantation |
Q92824585 | Cardiovascular and Metabolic Consequences of Liver Transplantation: A Review |
Q36713215 | Does situs inversus totalis preclude liver donation in living donor liver transplantation? A series of 3 cases from single institution |
Q90677008 | Domino Hepatocyte Transplantation: A Therapeutic Alternative for the Treatment of Acute Liver Failure |
Q33719955 | Effects of heme oxygenase-1-modified bone marrow mesenchymal stem cells on microcirculation and energy metabolism following liver transplantation |
Q51161462 | Functional liver tissue engineering by an adult mouse liver-derived neuro-glia antigen 2-expressing stem/progenitor population. |
Q89896426 | Impact of Having a Planned Additional Operation at Time of Liver Transplant on Graft and Patient Outcomes |
Q26745966 | Massive haemorrhage in liver transplantation: Consequences, prediction and management |
Q35855917 | Newly Developed Sarcopenia as a Prognostic Factor for Survival in Patients who Underwent Liver Transplantation |
Q39900273 | Pediatric liver transplantation: predictors of survival and resource utilization. |
Q91632163 | Pediatric living donor liver transplantation decade progress in Shanghai: Characteristics and risks factors of mortality |
Q36875036 | Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence |
Q58108550 | Risk factors of bloodstream infections in recipients after liver transplantation: a meta-analysis |
Q89742362 | Selected liver grafts from donation after circulatory death can be safely used for retransplantation - a multicenter retrospective study |
Q93379692 | Solid organ transplantation in the 21st century |
Q26799920 | Spectrum of biliary complications following live donor liver transplantation |
Q93115861 | Stem Cell-Based Therapies for Liver Diseases: An Overview and Update |
Search more.